Background: In vitro data derived from drug-specific T cell clones have revealed that heterogeneous T cell subsets with distinct phenotypes (CD4+ > CD8+) and cell functions (strong IL-5 production, cytotoxic potential) are generated. The aim of this study was to elaborate the relevance of these findings in vivo. Methods: Skin biopsy specimens from drug-induced maculopapular exanthema and normal skin were analyzed for CD4, CD8, CD25, HLA-DR, CD54, perforin, granzyme B, IL-5 and IFN-γ using immunohistochemistry. Results: The majority of infiltrating lymphocytes in maculopapular drug eruptions were CD4+. Both CD4+ and CD8+ T cells expressed perforin and granzyme B and were partly located at the dermoepidermal junction and in the epidermis. In addition, strong immunoreactivity for IL-5 and moderate immunoreactivity for IFN-γ were observed in the mononuclear cell infiltrate. Conclusions: Our data indicate that skin infiltrating T cells with a cytotoxic potential and the ability to produce IL-5 and IFN-γ may contribute to the damage of keratinocytes and the activation of eosinophils, which are typical features of drug-induced maculopapular exanthema.

1.
Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S: Role of T cells in drug allergies. Allergy 1998;53:225–232.
2.
Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ: Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995;55:2670–2678.
3.
Padovan E, Mauri-Hellweg D, Pichler WJ, Welzien HU: T cell recognition of penicillin G: Structural features determining antigenic specificity. Eur J Immunol 1996;26:42–48.
4.
Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ: Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997;100:136–141.
5.
Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ: Characterization of lidocaine-specific T cells. J Immunol 1997;158:1139–1148.
6.
Schnyder B, Frutig K, Yawalkar N, Limat A, Pichler WJ: T cell cytotoxicity in sulfamethoxazole induced skin reaction. Clin Exp Allergy 1998;28:1412–1417.
7.
Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Infiltration of cytotoxic T-cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000;30:847–855.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.